Science & Technology

Interleukin-1 Genetic Variations Influence Obesity Effect in Periodontal Disease Progression

Interleukin Genetics Provides New Evidence for Role of IL-1 Genetic Variations in Determining Impact of Obesity on Chronic Inflammatory Diseases

Waltham, Mass (August 23, 2016) – Interleukin Genetics, Inc. (OTCQB: ILIU) a life science company focused on the genetics of chronic inflammation, today announced the publication of the article “Influence of Obesity on Periodontitis Progression is Conditional on IL-1 Inflammatory Genetic Variation” in the Journal of Periodontology (http://www.joponline.org/doi/abs/10.1902/jop.2016.160408 ).The article is the result of a scientific collaboration with key researchers at Boston University and strongly supports the value of Interleukin-1 (IL-1) genetics in amplifying the negative impact of obesity.

“Interleukin Genetics continues to build scientific support for the clinical value of IL-1 genetic information,” said Ken Kornman, Chief Scientific Officer. […]

Interleukin Genetics Appoints Global Clinical Advisory Board To Guide Enhanced Healthcare Through Targeted Management of Systemic Inflammation

World-renowned team to advise on building practical population health initiatives

 

WALTHAM, MA – March 16, 2016 – Interleukin Genetics, Inc. (OTCQB: ILIU), a life sciences company focused on developing and marketing proprietary genetic tests for chronic diseases that reduce longevity and life quality, today announced the appointment of leading experts to its newly formed Clinical Advisory Board to advise the Company on clinical programs aimed at demonstrating the clinical and health economic benefits of targeted prevention and treatment of periodontitis, a common local inflammatory disease, in the management of several chronic diseases that affect widespread tissues and organs of the body.

“We are extremely pleased to bring together a ‘dream team’ of international experts at the intersection of systemic and […]

Interleukin Genetics and NYU School of Medicine Enter Into License Agreement to Enable Commercialization of a Genetics-Based Test for Osteoarthritis

New test will identify individuals at increased risk for progression of osteoarthritis, the most common adult joint disease

WALTHAM, MA and NEW YORK – July 15, 2015 – Interleukin Genetics, Inc. (OTCQB: ILIU) and NYU School of Medicine announced today they signed a license agreement to develop the first  genetic test of its kind to identify individuals at increased risk for progression of osteoarthritis (OA) and related complications, such as knee replacement. The agreement pertains to U.S. patent application No. 12/435,260 titled “Detecting Genetic Predisposition to Osteoarthritis Associated Conditions,” which is jointly owned by NYU School of Medicine and Interleukin Genetics.

OA is the most common adult joint disease, increasing in frequency and severity in all aging populations. The estimated prevalence in […]

Interleukin Genetics Granted Key European Patent Covering Inherent Health® Weight Management Genetic Test

WALTHAM, MA, April 15, 2015 – Interleukin Genetics, Inc. (OTCQB: ILIU) today announced that it has been granted a patent by the European Patent Office (EPO) covering the Company’s Inherent Health® Weight Management Genetic Test. The granted patent, entitled “Genetic Markers for Weight Management and Methods of Use Thereof,” has claims covering methods of determining a subject’s metabolic genotype and methods for selecting an appropriate therapeutic/dietary regimen or lifestyle recommendation based on the subject’s metabolic profile and susceptibility to adverse weight management issues. The European patent grants coverage of the Weight Management Genetic Test into 2029. Corresponding patents have been granted in major markets throughout the world including Eurasia, Japan, Mexico, Russia and New Zealand, and patent applications are […]

Interleukin Genetics Collaborators Present Scientific Research Supporting Weight Management Genetic Test at the 2015 Experimental Biology Annual Meeting

Preliminary Findings Show Greater Improvements in Body Composition When Diet Type is Matched to Genetic Profile

WALTHAM, MA, April 1, 2015 – Interleukin Genetics, Inc. (OTCQB: ILIU) today announced two late-breaking poster presentations supporting its Inherent Health® Weight Management Genetic Test at the 2015 Experimental Biology Annual Meeting taking place March 28 – April 1, 2015, in Boston.

“Data from these two important studies continue to enhance our understanding of the influence of genetics on both body composition and weight loss in response to particular diet and exercise programs,” stated Dr. Lynn Doucette-Stamm, PhD, Vice-President of Development and Clinical Operations of Interleukin.  “Improvements in body composition, particularly reductions in body fat percentage, is a key goal in any weight loss program.  […]

Interleukin Genetics Presents at Two Medical and Industry Conferences

WALTHAM, MA – March 16, 2015 – Interleukin Genetics, Inc. (OTCQB: ILIU) announced today that Kenneth S. Kornman, DDS, Ph.D., Chief Executive Officer of Interleukin Genetics, has presented at the following recent conferences:

  • National Health Policy Conference, sponsored by America’s Health Insurance Plans (AHIP) Dental Summit, which took place on Tuesday, March 10, 2015, in Washington, DC. Kornman’s presentation, titled “The Medical-Dental Connections,” covered the effects of moderate to severe periodontitis on whole body inflammation and its consequences, including certain diseases of aging such as cardiovascular disease.
  • Polish Society of Periodontology’s Spring Seminar, which took place on Friday, March 13, 2015, in Warsaw, Poland. Dr. Kornman’s presentation, titled “The Role of Inflammation in Periodontal Disease and other Chronic Diseases,” provided an overview […]

Interleukin-1 Gene Variations Interact With Obesity to Predict Periodontitis Progression

Interleukin Genetics to Present New Evidence on PerioPredict® and Periodontitis at the 2015 International Association for Dental Research Annual Meeting

WALTHAM, MA – March 12, 2015 – Interleukin Genetics, Inc. (OTCQB: ILIU) announced today a poster presentation at the 2015 International Association for Dental Research General Session & Exhibition, taking place March 11-14, 2015, in Boston.  The poster (#1290), titled “IL1 Genotype and Obesity Characteristics Interact to Influence Periodontitis Progression,” will be presented by Leon Wilkins, Ph.D., Senior Director of Translational Sciences, Interleukin Genetics, on Thursday, March 12, from 2:00-3:15 p.m. (ET).

“Using a longitudinal clinical database, the new evidence presented today demonstrates how the functional  IL-1 gene variants, shown to influence periodontitis (PD) severity, affect the previously demonstrated association between obesity […]

Interleukin’s PerioPredict®Receives 2014 DrBicuspid Dental Excellence Award

PerioPredict® Named “Best New Hygienist Product”
 
WALTHAM, MA – October 13, 2014 – Interleukin Genetics, Inc. (OTCQB: ILIU) announced today it received the 2014 DrBicuspid Dental Excellence Award for PerioPredict®, the Company’s commercially available genetic risk test for periodontal disease.  PerioPredict® was recognized as the “Best New Hygienist Product” and Kenneth S. Kornman, DDS, PhD, Chief Executive Officer, was presented with the award at this week’s 2014 American Dental Association (ADA) Annual Meeting.

“PerioPredict® is an innovative, easy-to-use tool that enables dental professionals to identify individuals with a higher risk of progressing to severe periodontal disease, and therefore better align preventive care to an individual patient’s needs,” said Dr. Kornman.  “We believe that PerioPredict® offers the potential to improve outcomes for dental […]

IL-1 Evidence

 

TitlePublicationAuthorsLink
    
Evidence for PerioPredict®Interleukin Genetics, Sep 2014Kornman KS, […]